Royal Harbor Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-43,382
Closed -$2.1M 51
2023
Q3
$2.1M Buy
43,382
+2,027
+5% +$108K 1.1% 21
2023
Q2
$2.33M Buy
+41,355
New +$2.28M 1.14% 24

Other funds holding IHI

Royal Harbor Partners's IHI Position: Q4 2023 in Review

Royal Harbor Partners sold out of iShares US Medical Devices ETF (IHI) in Q4 2023, closing a stake of 43,382 shares — an estimated $2.1M sold.

Royal Harbor Partners first reported a position in IHI in Q2 2023 and held it in 2 quarters. The position peaked at $2.33M in Q2 2023. 574 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

  • Royal Harbor Partners reported no remaining iShares US Medical Devices ETF position as of Q4 2023 after selling out during the quarter.
  • Royal Harbor Partners sold 43,382 iShares US Medical Devices ETF shares in Q4 2023, an estimated $2.1M.
  • Royal Harbor Partners first reported a position in iShares US Medical Devices ETF in Q2 2023 and held it in 2 quarters.
  • Royal Harbor Partners's iShares US Medical Devices ETF position peaked at $2.33M in Q2 2023.
  • 574 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on Royal Harbor Partners's 13F filing for Q4 2023, filed 8 Feb 2024.